A Study to Evaluate ONO-4474 in Patients With Pain Due to Osteoarthritis of the Knee

Summary

The purpose of this phase 2, randomised, double-blind, placebo controlled, parallel group, multicentre study is to investigate the efficacy, safety, tolerability and pharmacokinetics of a compound ONO-4474 in patients with moderate to severe pain due to osteoarthritis of the knee following 4 weeks of oral administration of ONO-4474.

Timeline

Start

2017-01

Primary completion

2018-01-09

Completion

2018-01-09

Outcome

Outcome not reported

Stopped (Business): “The study was stopped for business reasons. No safety issues were reported.”

Drugs

Indications